Today, biospecimen collections are used by multiple groups for various aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage, and tracking of biospecimens are vital components allowing researchers to better link molecular and clinical information. Thus, by necessity, biobanking is both a science and a business. Cambridge Healthtech Institute’s fourth annual Leaders in Biobanking Congress addresses both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today’s cutting edge research.
Key Features
- PRESENTATIONS
Gain insight from biobanking managers and biopreservation scientists and delve into the molecular advances in biomedical science.
- PANEL DISCUSSIONS
Determine best practices in biopreservation protocols.
- CASE STUDIES
Analyze ongoing biobanking partnerships.
- NETWORKING OPPORTUNITIES
Join discussion groups and dedicated exhibit hall and poster viewing hours.
- SHORT COURSES
Attend interactive courses designed as a great introduction for those who are new to a particular discipline or as a refresher for those who want to brush up on their knowledge or expand their horizons.
Co-Hosted by
Includes an Onsite Tour of LabCorp’s Center for Molecular Biology & Pathology (CMBP) in the Research Triangle Park
|